Caricamento...
Normal antibody response after COVID-19 during treatment with cladribine
Cladribine is a highly effective, recently available treatment in multiple sclerosis. This case report describes a patient with COVID-19 infection during second year treatment with cladribine. The infection was mild and she was able to mount an adequate immune response with detectable antibodies thr...
Salvato in:
| Pubblicato in: | Mult Scler Relat Disord |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier B.V.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7832623/ https://ncbi.nlm.nih.gov/pubmed/32882501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2020.102476 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|